Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;58(11):1199-205.
doi: 10.1136/jcp.2004.024786.

Prognostic value of activated Akt expression in oral squamous cell carcinoma

Affiliations

Prognostic value of activated Akt expression in oral squamous cell carcinoma

J Lim et al. J Clin Pathol. 2005 Nov.

Abstract

Background: Akt is a serine/threonine kinase that plays an important role in tumorigenesis and influences prognosis in several cancers. However, its importance in oral squamous cell carcinomas (OSCC) has not been elucidated.

Aim: To investigate the association between the expression of activated Akt, clinicopathological factors, and E-cadherin, PCNA (proliferating cell nuclear antigen), and VEGF (vascular endothelial growth factor) expression to verify the validity of Akt as a prognostic factor in OSCC.

Methods: Phosphorylated Akt (p-Akt), E-cadherin, PCNA, and VEGF expression were assessed immunohistochemically in 84 OSCCs. The results were analysed in relation to clinicopathological factors.

Results: p-Akt was expressed in 29 cases. It was significantly correlated with lymph node metastasis, TNM stage, and E-cadherin expression. Univariate analysis showed that p-Akt expression, E-cadherin expression, PCNA expression, differentiation, tumour size, lymph node metastasis, TNM stage, and recurrence correlated with prognosis. Multivariate analysis showed that p-Akt expression is an independent prognostic factor in patients with OSCC.

Conclusions: This study revealed that Akt activation is a significant prognostic indicator for OSCC and is correlated with E-cadherin expression. The inhibition of Akt is a possible molecular approach to the treatment of OSCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunohistochemical staining in oral squamous cell carcinoma. (A) Positive expression of phosphorylated Akt (original magnification, ×200); (B) positive expression of E-cadherin (original magnification, ×200); (C) high expression of PCNA (original magnification, ×100); (D) positive expression of VEGF (original magnification, ×200).
Figure 2
Figure 2
Survival curves of patients with oral squamous cell carcinoma according to (A) phosphorylated Akt (p-Akt) expression, (B) p-Akt expression in T1 and T2 tumours, (C) E-cadherin expression, (D) lymph node (LN) metastasis, (E) tumour size, and (F) clinical stage (Kaplan–Meier method).

Similar articles

Cited by

References

    1. Silverman SJ. Oral cancer. 4th ed. Atlanta: American Cancer Society 1998.
    1. Sobin LHWC. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss UICC, 1997.
    1. Houck JRMJ. Management of cervical lymph nodes in squamous carcinomas of the head and neck. Semin Surg Oncol 1995;11:228–39. - PubMed
    1. Tankere F, Camproux A, Barry B, et al. Prognostic value of lymph node involvement in oral cancers: a study of 137 cases. Laryngoscope 2000;110:2061–5. - PubMed
    1. Piattelli A, Rubini C, Fioroni M, et al. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity. J Oral Maxillofac Surg 2002;60:532–40. - PubMed

Publication types

MeSH terms